277 related articles for article (PubMed ID: 19139031)
21. Antiandrogenic contraceptives increase serum adiponectin in obese polycystic ovary syndrome patients.
Luque-Ramírez M; Alvarez-Blasco F; Escobar-Morreale HF
Obesity (Silver Spring); 2009 Jan; 17(1):3-9. PubMed ID: 18997670
[TBL] [Abstract][Full Text] [Related]
22. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
Panidis D; Georgopoulos NA; Piouka A; Katsikis I; Saltamavros AD; Decavalas G; Diamanti-Kandarakis E
Gynecol Endocrinol; 2011 Aug; 27(8):587-92. PubMed ID: 20836726
[TBL] [Abstract][Full Text] [Related]
23. The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: an updated systematic review.
Jing Z; Liang-Zhi X; Tai-Xiang W; Ying T; Yu-Jian J
Gynecol Endocrinol; 2008 Oct; 24(10):590-600. PubMed ID: 19012104
[TBL] [Abstract][Full Text] [Related]
24. Doppler analysis of ovarian stromal blood flow changes after treatment with metformin versus ethinyl estradiol-cyproterone acetate in women with polycystic ovarian syndrome: A randomized controlled trial.
Sahu A; Tripathy P; Mohanty J; Nagy A
J Gynecol Obstet Hum Reprod; 2019 May; 48(5):335-339. PubMed ID: 30316907
[TBL] [Abstract][Full Text] [Related]
25. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Fruzzetti F; Perini D; Lazzarini V; Parrini D; Gambacciani M; Genazzani AR
Fertil Steril; 2010 Oct; 94(5):1793-8. PubMed ID: 19931080
[TBL] [Abstract][Full Text] [Related]
26. Differential Effects on Haemostatic Markers by Metformin and the Contraceptive Pill: A Randomized Comparative Trial in PCOS.
Burchall GF; Piva TJ; Ranasinha S; Teede HJ
Thromb Haemost; 2017 Nov; 117(11):2053-2062. PubMed ID: 29202210
[No Abstract] [Full Text] [Related]
27. Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.
Karakurt F; Carlioglu A; Kaygusuz I; Gumus II; Uz B; Akdeniz D
Arch Gynecol Obstet; 2014 Jan; 289(1):135-40. PubMed ID: 23880889
[TBL] [Abstract][Full Text] [Related]
28. The effect of ethinyl estradiol-cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome.
Gul OB; Somunkiran A; Yucel O; Demirci F; Ozdemir I
Arch Gynecol Obstet; 2008 Jan; 277(1):25-30. PubMed ID: 17618446
[TBL] [Abstract][Full Text] [Related]
29. A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome.
Mhao NS; Al-Hilli AS; Hadi NR; Jamil DA; Al-Aubaidy HA
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S95-8. PubMed ID: 26703220
[TBL] [Abstract][Full Text] [Related]
30. The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome.
Carlioglu A; Kaygusuz I; Karakurt F; Gumus II; Uysal A; Kasapoglu B; Armutcu F; Uysal S; Keskin EA; Koca C
Arch Gynecol Obstet; 2014 Nov; 290(5):929-35. PubMed ID: 24840107
[TBL] [Abstract][Full Text] [Related]
31. Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome.
Essah PA; Arrowood JA; Cheang KI; Adawadkar SS; Stovall DW; Nestler JE
Fertil Steril; 2011 Aug; 96(2):501-504.e2. PubMed ID: 21733508
[TBL] [Abstract][Full Text] [Related]
32. [Combined use of metformin and Diane35 in polycystic ovary syndrome].
Mitkov M; Pekhlivanov B; Terzieva D
Akush Ginekol (Sofiia); 2004; 43(3):34-7. PubMed ID: 15341255
[TBL] [Abstract][Full Text] [Related]
33. Treatment of polycystic ovary syndrome (PCOS) with metformin ameliorates insulin resistance in parallel with the decrease of serum interleukin-6 concentrations.
Luque-Ramírez M; Escobar-Morreale HF
Horm Metab Res; 2010 Oct; 42(11):815-20. PubMed ID: 20730705
[TBL] [Abstract][Full Text] [Related]
34. Metformin administration improves endothelial function in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Alexandraki K; Protogerou A; Piperi C; Papamichael C; Aessopos A; Lekakis J; Mavrikakis M
Eur J Endocrinol; 2005 May; 152(5):749-56. PubMed ID: 15879361
[TBL] [Abstract][Full Text] [Related]
35. The effects of treatment with drospirenone/ethinyl oestradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome.
Kaya MG; Calapkorur B; Karaca Z; Yildirim S; Celik A; Akpek M; Unluhizarci K; Kelestimur F
Clin Endocrinol (Oxf); 2012 Dec; 77(6):885-92. PubMed ID: 22563947
[TBL] [Abstract][Full Text] [Related]
36. Effects of metformin or an oral contraceptive containing cyproterone acetate on serum c-reactive protein, interleukin-6 and soluble vascular cell adhesion molecule-1 concentrations in women with polycystic ovary syndrome.
Dardzińska JA; Rachoń D; Kuligowska-Jakubowska M; Aleksandrowicz-Wrona E; Płoszyński A; Wyrzykowski B; Lysiak-Szydłowska W
Exp Clin Endocrinol Diabetes; 2014 Feb; 122(2):118-25. PubMed ID: 24554512
[TBL] [Abstract][Full Text] [Related]
37. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
38. Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.
Song J; Ruan X; Gu M; Wang L; Wang H; Mueck AO
Gynecol Endocrinol; 2018 May; 34(5):413-417. PubMed ID: 29172796
[TBL] [Abstract][Full Text] [Related]
39. Increased thrombin generation in women with polycystic ovary syndrome: A pilot study on the effect of metformin and oral contraceptives.
Glintborg D; Sidelmann JJ; Altinok ML; Mumm H; Andersen M
Metabolism; 2015 Oct; 64(10):1272-8. PubMed ID: 26194691
[TBL] [Abstract][Full Text] [Related]
40. Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome.
Karakurt F; Gumus II; Bavbek N; Kargili A; Koca C; Selcoki Y; Ozbek M; Kosar A; Akcay A
Gynecol Endocrinol; 2008 Sep; 24(9):491-7. PubMed ID: 18958767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
